Wave Life Sciences Ltd. — Director's Dealing 2020

Jan 18, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Wave Life Sciences Ltd. (WVE)
CIK: 0001631574
Period of Report: 2020-01-09

Reporting Person: Gaiero David G (Interim CFO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	7043	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Share Option (Right to Buy)	$22.10	2027-10-03	Ordinary Shares (19000)		Direct

Footnotes

F1: Consists of 541 ordinary shares; 2,502 restricted share units (RSUs) that vest in four equal annual installments beginning on February 1, 2019 through February 1, 2022; and 4,000 RSUs that vest in four equal annual installments of 25% beginning on February 1, 2020 through February 1, 2023.

F2: The option vests as to 25% of the shares on July 10, 2018 and vests as to an additional 2.0833% of the shares monthly thereafter until July 10, 2021.